1456 related articles for article (PubMed ID: 25597592)
1. Individualized antithrombotic therapy.
Lüscher TF; Steffel J
Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
[TBL] [Abstract][Full Text] [Related]
3. Why we should not skip aspirin in cardiovascular prevention.
Schrör K
Hamostaseologie; 2016; 36(1):33-43. PubMed ID: 25891122
[TBL] [Abstract][Full Text] [Related]
4. Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation?
Spinthakis N; Farag M; Akhtar Z; Gorog DA
Curr Vasc Pharmacol; 2018; 16(5):427-436. PubMed ID: 29345587
[TBL] [Abstract][Full Text] [Related]
5. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM
Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289
[TBL] [Abstract][Full Text] [Related]
7. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
[TBL] [Abstract][Full Text] [Related]
8. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.
Ganetsky VS; Hadley DE; Thomas TF
Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703
[TBL] [Abstract][Full Text] [Related]
9. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
Thompson PL; Verheugt FW
Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
[TBL] [Abstract][Full Text] [Related]
10. Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?
Rubboli A; Oldgren J; Marìn F; Lip G
Intern Emerg Med; 2013 Dec; 8(8):673-80. PubMed ID: 24136072
[TBL] [Abstract][Full Text] [Related]
11. Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?
Asencio LA; Huang JJ; Alpert JS
Am J Med; 2014 Jul; 127(7):579-85. PubMed ID: 24608021
[TBL] [Abstract][Full Text] [Related]
12. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
Rubboli A; Agewall S; Huber K; Lip GY
Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
[TBL] [Abstract][Full Text] [Related]
13. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
Cairns JA; McMurtry MS
Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
[TBL] [Abstract][Full Text] [Related]
14. Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
Sindet-Pedersen C; Staerk L; Lamberts M; Gerds TA; Berger JS; Nissen Bonde A; Langtved Pallisgaard J; Hansen ML; Torp-Pedersen C; Gislason GH; Bjerring Olesen J
Heart; 2018 Jun; 104(11):912-920. PubMed ID: 29092916
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.
Caprio FZ; Bernstein RA; Alberts MJ; Curran Y; Bergman D; Korutz AW; Syed F; Ansari SA; Prabhakaran S
Cerebrovasc Dis; 2014; 38(4):247-53. PubMed ID: 25401389
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic and anticoagulant therapy for atrial fibrillation.
Dzeshka MS; Lip GY
Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
[TBL] [Abstract][Full Text] [Related]
17. Novel oral anticoagulants in acute coronary syndrome.
Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA
Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603
[TBL] [Abstract][Full Text] [Related]
18. High platelet reactivity--the challenge of prolonged anticoagulation therapy after ACS.
Brouwer MA; Jaspers Focks J; Verheugt FW
Thromb Haemost; 2013 May; 109(5):799-807. PubMed ID: 23426079
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.
Weisshaar S; Litschauer B; Gouya G; Mayer P; Smerda L; Kapiotis S; Kyrle PA; Eichinger S; Wolzt M
J Thromb Haemost; 2014 Nov; 12(11):1850-60. PubMed ID: 25211369
[TBL] [Abstract][Full Text] [Related]
20. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
